361 related articles for article (PubMed ID: 31915250)
21. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
[TBL] [Abstract][Full Text] [Related]
22. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; Quinoñes-Hinojosa A; Yarema KJ
ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
[TBL] [Abstract][Full Text] [Related]
23. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
24.
Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
[TBL] [Abstract][Full Text] [Related]
25. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC; Nöt LG; Fülöp N; Marchase RB
Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
27. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
Lam C; Low JY; Tran PT; Wang H
Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
[TBL] [Abstract][Full Text] [Related]
28. Hexosamine biosynthetic pathway and
Kim DY; Park J; Han IO
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
[TBL] [Abstract][Full Text] [Related]
29. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
[TBL] [Abstract][Full Text] [Related]
30. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
31. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.
Taparra K; Wang H; Malek R; Lafargue A; Barbhuiya MA; Wang X; Simons BW; Ballew M; Nugent K; Groves J; Williams RD; Shiraishi T; Verdone J; Yildirir G; Henry R; Zhang B; Wong J; Wang KK; Nelkin BD; Pienta KJ; Felsher D; Zachara NE; Tran PT
J Clin Invest; 2018 Nov; 128(11):4924-4937. PubMed ID: 30130254
[TBL] [Abstract][Full Text] [Related]
32. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
[TBL] [Abstract][Full Text] [Related]
33. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.
Riegger J; Baumert J; Zaucke F; Brenner RE
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298867
[TBL] [Abstract][Full Text] [Related]
34. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
[TBL] [Abstract][Full Text] [Related]
35. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
36. Hexosamine Biosynthetic Pathway and Glycosylation Regulate Cell Migration in Melanoma Cells.
de Queiroz RM; Oliveira IA; Piva B; Bouchuid Catão F; da Costa Rodrigues B; da Costa Pascoal A; Diaz BL; Todeschini AR; Caarls MB; Dias WB
Front Oncol; 2019; 9():116. PubMed ID: 30891426
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
[TBL] [Abstract][Full Text] [Related]
38. Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.
Carvalho-Cruz P; Alisson-Silva F; Todeschini AR; Dias WB
Dev Dyn; 2018 Mar; 247(3):481-491. PubMed ID: 28722313
[TBL] [Abstract][Full Text] [Related]
39. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.
Luo B; Soesanto Y; McClain DA
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):651-7. PubMed ID: 18174452
[TBL] [Abstract][Full Text] [Related]
40. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]